Medicago Inc MDCGF

Nice!

[Indicator]

"... we are in a good position toreport multiple sets of data next quarter including data from thistrial and final phase II data for our pandemic influenza candidate. I amconfident that the quality of data to be obtained from these clinicaltrials and our other solid results to date will further positionMedicago as a leader in the development of rapid and cost-effectivevaccines."

Just when you resign yourself to exercising patience for the next stock move, they throw out a nice curve ball  :-)

I hope everyone has been getting their fill under .50.   With continued good trial results, sooner or later this has to explode.